Calumet Inc: Why Investors Shouldn’t Get Rid Of CLMT Stock In 2025

In the last trading session, 1.09 million shares of the Calumet Inc (NASDAQ:CLMT) were traded, and its beta was 1.86. Most recently the company’s share price was $16.16, and it changed around -$0.05 or -0.31% from the last close, which brings the market valuation of the company to $1.39B. CLMT currently trades at a discount to its 52-week high of $25.29, offering almost -56.5% off that amount. The share price’s 52-week low was $9.97, which indicates that the current value has risen by an impressive 38.3% since then. We note from Calumet Inc’s average daily trading volume that its 10-day average is 1.38 million shares, with the 3-month average coming to 1.01 million.

Calumet Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 1 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended CLMT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Calumet Inc is expected to report earnings per share of -0.38 for the current quarter.

Calumet Inc (NASDAQ:CLMT) trade information

Instantly CLMT has showed a red trend with a performance of -0.31% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 17.88 on recent trading dayincreased the stock’s daily price by 9.62%. The company’s shares are currently down -26.61% year-to-date, but still down -11.89% over the last five days. On the other hand, Calumet Inc (NASDAQ:CLMT) is -24.42% down in the 30-day period. We can see from the shorts that 6.61 million shares have been sold at a short interest cover period of 6.28 day(s).

The consensus price target as assigned by Wall Street analysts is $22.35, which translates to bulls needing to increase their stock price by 27.7% from its current value. Analyst projections state that CLMT is forecast to be at a low of $15.7 and a high of $29.

Calumet Inc (CLMT) estimates and forecasts

The year-over-year growth rate is expected to be -0.46%, down from the previous year.

Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 921.76M in revenue for the current quarter. 4 analysts expect Calumet Inc to make 1.01B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 976.5M and 1.01B respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -5.61%. Forecasts for the next quarter put sales growth at 0.76%.

Calumet Inc earnings are expected to increase by -468.14% in 2025, but the outlook is positive 0.13% per year for the next five years.

CLMT Dividends

Calumet Inc’s next quarterly earnings report is expected to be released in March. The average dividend yield for the past five years averaged 14.83 per year.

Calumet Inc (NASDAQ:CLMT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 21.18% of Calumet Inc shares, and 36.25% of them are in the hands of institutional investors. The stock currently has a share float of 45.99%. Calumet Inc stock is held by 118.0 institutions, with WASSERSTEIN DEBT OPPORTUNITIES MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 8.5547% of the shares, which is about 6.89 million shares worth $110.61 million.

ADAMS ASSET ADVISORS, LLC, with 6.5187% or 5.25 million shares worth $84.28 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 2.74 shares worth $44.33 million, making up 3.19% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.02 shares worth around $16.54 million, which represents about 1.19% of the total shares outstanding.